Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
92M
Market Cap:
$0.58B
Avg Volume:
939212
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Decent Monday Session
Dec 11, 2012 01:00 AM |
AAPL
,
ABMD
,
ACUR
,
AMZN
,
ANR
,
CBMX
Volatile, Consolidation Session
Sep 19, 2012 01:19 AM |
AAPL
,
ARNA
,
CPRX
,
ENR
,
ETN
,
GOOG
A Spectacular Session Indeed!
Sep 06, 2012 11:08 PM |
AAPL
,
AMZN
,
BDSI
,
CAVM
,
DB
,
FSLR
More Articles on OREX..
Press Releases
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
May 17, 2013 04:01 PM |
OREX
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013 04:01 PM |
OREX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 07, 2013 11:52 AM |
OREX
More Press Releases on OREX..
SEC Filings
Form 4 Orexigen Therapeutics, For: Mar 11 Filed by: Booth Mark D (10K)
Mar 12, 2013 08:43 PM
Form 4 Orexigen Therapeutics, For: Feb 15 Filed by: Klassen Preston (10K)
Feb 19, 2013 09:08 PM
Form 4 Orexigen Therapeutics, For: Feb 15 Filed by: Hagan Joseph P (10K)
Feb 19, 2013 09:08 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
OREX
Compare to S&P
YTD
18.66 %
8.82 %
4 Weeks
8.16 %
8.27 %
12 Weeks
7.60 %
3.98 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
6.82 %
EPS Growth in Last Year:
-355.56 %
Sales Growth in Last Quarter:
0.00 %
Sales Growth in Last Quarter:
0.00 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##